Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19

#COVID Levels of IL-1ß and MCP-1 at baseline and MCP-1, IP-10 and RANTES on day 7 were associated with a favorable outcome across several endpoints. These cytokines should be included in future trials for further evaluation as predictive factors https://t.

Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19 https://t.co/uBaIXe6Xrr

Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19: Objectives, To determine the profile of cytokines in patients with severe… #immunology https://t.co/83hDvQAt

Cytokine levels asso with favorable clinical outcome in the CAPSID randomized trial of CP in patients with severe COVID19: majority of cytokines hv signif changes from baseline to D7. Some were strongly correlated amongst each other https://t.co/UmsxQkmd5